VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Rob McWhirter

<< Previous

Bullboard Posts

Next >>

Comment by Yajneon Apr 12, 2021 2:09pm

342 Views

Post# 32978508

RE:RE:Rob McWhirter

Agreed Pandora, but it appears some accumulation going on in market today...maybe some new eyes on VPT due to McWhirter comments?

Pandora wrote:

Pandora wrote:
A very good pump by Rob McWhirter on BNN MarketCall a few minutes ago. He was very high on the China component mentioning a possibilty of the Chinese FDA requiring the technology in 'all' hospitals.

Looking at the action re price and volume I can't believe how quiet the board is. Almost like they give no credence to McWhirter and his comments but they're not even making that comment. A little different -- that's all.